• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型氟碳基超声心动图造影剂QW7437的安全性和有效性

Safety and efficacy of QW7437, a new fluorocarbon-based echocardiographic contrast agent.

作者信息

Main M L, Escobar J F, Hall S A, Grayburn P A

机构信息

Department of Medicine, UT Southwestern Medical Center, Dallas 75235-9047, USA.

出版信息

J Am Soc Echocardiogr. 1997 Oct;10(8):798-804. doi: 10.1016/s0894-7317(97)70038-5.

DOI:10.1016/s0894-7317(97)70038-5
PMID:9356943
Abstract

The aim of this study was to evaluate the safety and efficacy of QW7437, a new fluorocarbon-based transpulmonary myocardial echocardiographic contrast agent. QW7437 is an anionically charged 2% dodecafluoropentane emulsion molecule, similar to EchoGen, a contrast agent previously shown to be efficacious in providing myocardial opacification by means of venous injection. This new agent has theoretical potential to provide greater safety and efficacy as a result of (1) reduced adherence to the negatively charged vascular endothelium and (2) reduced microbubble coalescence. Myocardial contrast echocardiography was performed in 10 dogs to evaluate the safety and efficacy of this agent. QW7437 (0.05 ml/kg) was injected as an intravenous bolus during intermittent harmonic epicardial imaging. Hemodynamic variables including heart rate, blood pressure, pulmonary artery pressure, pulmonary capillary wedge pressure, cardiac output, and arterial blood gases were determined at baseline and serially after contrast administration. Left ventricular fractional area shortening the regional myocardial blood flow at rest and during hyperemia (adenosine 140 micrograms/kg/min) were measured before and after contrast echocardiography. QW7437 provided dense myocardial opacification which persisted for more than 2 minutes in all subjects. This prolonged contrast effect did not result in significant changes in any hemodynamic variables, left ventricular function, or myocardial blood flow. Future studies should address the potential of this agent for human use.

摘要

本研究的目的是评估QW7437的安全性和有效性。QW7437是一种新型的基于氟碳的经肺心肌超声心动图造影剂。QW7437是一种带阴离子电荷的2%十二氟戊烷乳剂分子,类似于EchoGen,一种先前已证明通过静脉注射可有效实现心肌显影的造影剂。由于(1)减少了与带负电荷的血管内皮的粘附以及(2)减少了微泡聚并,这种新型造影剂具有提供更高安全性和有效性的理论潜力。对10只犬进行了心肌对比超声心动图检查以评估该造影剂的安全性和有效性。在间歇性谐波心外膜成像期间,将QW7437(0.05 ml/kg)作为静脉推注给药。在基线时以及造影剂给药后连续测定血流动力学变量,包括心率、血压、肺动脉压、肺毛细血管楔压、心输出量和动脉血气。在对比超声心动图检查前后测量左心室缩短分数、静息和充血(腺苷140微克/千克/分钟)时的局部心肌血流量。QW7437在所有受试者中均提供了致密的心肌显影,且持续超过2分钟。这种延长的对比效果并未导致任何血流动力学变量、左心室功能或心肌血流量发生显著变化。未来的研究应探讨该造影剂用于人体的潜力。

相似文献

1
Safety and efficacy of QW7437, a new fluorocarbon-based echocardiographic contrast agent.新型氟碳基超声心动图造影剂QW7437的安全性和有效性
J Am Soc Echocardiogr. 1997 Oct;10(8):798-804. doi: 10.1016/s0894-7317(97)70038-5.
2
Hemodynamic characteristics, myocardial kinetics and microvascular rheology of FS-069, a second-generation echocardiographic contrast agent capable of producing myocardial opacification from a venous injection.FS-069的血流动力学特征、心肌动力学及微血管流变学,FS-069是一种第二代超声心动图造影剂,能够通过静脉注射实现心肌显影。
J Am Coll Cardiol. 1996 Nov 1;28(5):1292-300. doi: 10.1016/S0735-1097(96)00328-2.
3
Safety and efficacy of a new transpulmonary echo contrast agent in echocardiographic studies in patients.一种新型经肺超声造影剂在患者超声心动图研究中的安全性和有效性。
J Am Coll Cardiol. 1993 Oct;22(4):1193-8. doi: 10.1016/0735-1097(93)90437-6.
4
Myocardial contrast echocardiography: reliable, safe, and efficacious myocardial perfusion assessment after intravenous injections of a new echocardiographic contrast agent.
Am Heart J. 1996 Oct;132(4):871-81. doi: 10.1016/s0002-8703(96)90324-5.
5
Italian Society of Cardiovascular Echography (SIEC) Consensus Conference on the state of the art of contrast echocardiography.意大利心血管超声学会(SIEC)关于超声造影技术现状的共识会议
Ital Heart J. 2004 Apr;5(4):309-34.
6
Myocardial imaging with a new transpulmonary lipid-fluorocarbon echo contrast agent: experimental studies in pigs.新型经肺脂质氟碳超声造影剂的心肌成像:猪的实验研究
Am Heart J. 1996 Nov;132(5):938-45. doi: 10.1016/s0002-8703(96)90002-2.
7
Peripheral intravenous myocardial contrast echocardiography using a 2% dodecafluoropentane emulsion: identification of myocardial risk area and infarct size in the canine model of ischemia.
J Am Coll Cardiol. 1995 Nov 1;26(5):1340-7. doi: 10.1016/0735-1097(95)00306-1.
8
Prolonged myocardial contrast echocardiography via peripheral venous administration of QW3600 injection (EchoGen): its efficacy and side effects.
J Am Soc Echocardiogr. 1997 Jan-Feb;10(1):11-24. doi: 10.1016/s0894-7317(97)80028-4.
9
Flow dynamics of QW7437, a new dodecafluoropentane ultrasound contrast agent, in the microcirculation: microvascular mechanisms for persistent tissue echo enhancement.新型十二氟戊烷超声造影剂QW7437在微循环中的流动动力学:组织回声持续增强的微血管机制
J Am Coll Cardiol. 1999 Aug;34(2):578-86. doi: 10.1016/s0735-1097(99)00209-0.
10
Intravenous perfluoropropane-exposed sonicated dextrose albumin produces myocardial ultrasound contrast that correlates with coronary blood flow.静脉注射全氟丙烷暴露的超声处理葡萄糖白蛋白可产生与冠状动脉血流相关的心肌超声造影。
J Am Soc Echocardiogr. 1995 Sep-Oct;8(5 Pt 1):710-8. doi: 10.1016/s0894-7317(05)80386-4.

引用本文的文献

1
In vivo high-frequency, contrast-enhanced ultrasonography of uveal melanoma in mice: imaging features and histopathologic correlations.体内高频对比增强超声在小鼠葡萄膜黑色素瘤中的应用:影像学特征与组织病理学相关性。
Invest Ophthalmol Vis Sci. 2011 Apr 1;52(5):2662-8. doi: 10.1167/iovs.10-6794. Print 2011 Apr.
2
Safety of ultrasound contrast agents.超声造影剂的安全性。
Eur Radiol. 2005 May;15(5):941-5. doi: 10.1007/s00330-004-2601-0. Epub 2005 Jan 21.
3
New ultrasound contrast agents for left ventricular and myocardial opacification.
用于左心室和心肌显影的新型超声造影剂。
Herz. 1998 Dec;23(8):474-82. doi: 10.1007/BF03043754.